• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人谷氨酸羧肽酶 II 催化叶酸多聚γ-L-谷氨酸水解的结构和生化特性。

Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II.

机构信息

Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague 6, Czech Republic; Department of Biochemistry, Faculty of Sciences, Charles University in Prague, Czech Republic.

出版信息

FEBS J. 2014 Jul;281(14):3228-42. doi: 10.1111/febs.12857. Epub 2014 Jun 17.

DOI:10.1111/febs.12857
PMID:24863754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6257983/
Abstract

In addition to its well-characterized role in the central nervous system, human glutamate carboxypeptidase II (GCPII; Uniprot ID Q04609) acts as a folate hydrolase in the small intestine, participating in the absorption of dietary polyglutamylated folates (folyl-n-γ-l-glutamic acid), which are the provitamin form of folic acid (also known as vitamin B9 ). Despite the role of GCPII as a folate hydrolase, nothing is known about the processing of polyglutamylated folates by GCPII at the structural or enzymological level. Moreover, many epidemiologic studies on the relationship of the naturally occurring His475Tyr polymorphism to folic acid status suggest that this polymorphism may be associated with several pathologies linked to impaired folate metabolism. In the present study, we report: (a) a series X-ray structures of complexes between a catalytically inactive GCPII mutant (Glu424Ala) and a panel of naturally occurring polyglutamylated folates; (b) the X-ray structure of the His475Tyr variant at a resolution of 1.83 Å; (c) the study of the recently identified arene-binding site of GCPII through mutagenesis (Arg463Leu, Arg511Leu and Trp541Ala), inhibitor binding and enzyme kinetics with polyglutamylated folates as substrates; and (d) a comparison of the thermal stabilities and folate-hydrolyzing activities of GCPII wild-type and His475Tyr variants. As a result, the crystallographic data reveal considerable details about the binding mode of polyglutamylated folates to GCPII, especially the engagement of the arene binding site in recognizing the folic acid moiety. Additionally, the combined structural and kinetic data suggest that GCPII wild-type and His475Tyr variant are functionally identical.

摘要

除了在中枢神经系统中具有特征明显的作用外,人类谷氨酸羧肽酶 II(GCPII;Uniprot ID Q04609)在小肠中作为叶酸水解酶发挥作用,参与膳食多聚谷氨酸化叶酸(叶酸 - n-γ-L-谷氨酸)的吸收,这是叶酸的维生素前体形式(也称为维生素 B9)。尽管 GCPII 作为叶酸水解酶发挥作用,但在结构或酶学水平上,尚未了解 GCPII 对多聚谷氨酸化叶酸的加工。此外,许多关于天然存在的 His475Tyr 多态性与叶酸状态关系的流行病学研究表明,这种多态性可能与几种与叶酸代谢受损相关的病理有关。在本研究中,我们报告:(a)一系列与一组天然多聚谷氨酸化叶酸结合的催化失活 GCPII 突变体(Glu424Ala)复合物的 X 射线结构;(b)分辨率为 1.83 Å 的 His475Tyr 变体的 X 射线结构;(c)通过突变(Arg463Leu、Arg511Leu 和 Trp541Ala)、抑制剂结合和酶动力学研究最近发现的 GCPII 芳基结合位点,使用多聚谷氨酸化叶酸作为底物;(d)GCPII 野生型和 His475Tyr 变体的热稳定性和叶酸水解活性的比较。结果,晶体学数据揭示了多聚谷氨酸化叶酸与 GCPII 结合模式的大量细节,特别是芳基结合位点在识别叶酸部分中的参与。此外,综合结构和动力学数据表明,GCPII 野生型和 His475Tyr 变体在功能上是相同的。

相似文献

1
Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II.人谷氨酸羧肽酶 II 催化叶酸多聚γ-L-谷氨酸水解的结构和生化特性。
FEBS J. 2014 Jul;281(14):3228-42. doi: 10.1111/febs.12857. Epub 2014 Jun 17.
2
Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia.谷氨酸羧肽酶II:一种与血清叶酸水平降低和高同型半胱氨酸血症相关的多态性。
Hum Mol Genet. 2000 Nov 22;9(19):2837-44. doi: 10.1093/hmg/9.19.2837.
3
Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.人谷氨酸羧肽酶II与其底物类似物之间相互作用的结构基础。
J Mol Biol. 2008 Mar 7;376(5):1438-50. doi: 10.1016/j.jmb.2007.12.066. Epub 2008 Jan 5.
4
Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility.C1561T 谷氨酸羧肽酶 II(GCPII)基因多态性在改变疾病易感性方面的矛盾作用。
Gene. 2012 Apr 15;497(2):273-9. doi: 10.1016/j.gene.2012.01.055. Epub 2012 Jan 31.
5
Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis.通过定点诱变对谷氨酸羧肽酶II活性位点进行定位。
FEBS J. 2007 Sep;274(18):4731-41. doi: 10.1111/j.1742-4658.2007.06021.x. Epub 2007 Aug 21.
6
Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.鉴定谷氨酸羧肽酶II上蛋白水解活性所必需的N-糖基化位点。
Protein Sci. 2004 Jun;13(6):1627-35. doi: 10.1110/ps.04622104.
7
Reaction mechanism of glutamate carboxypeptidase II revealed by mutagenesis, X-ray crystallography, and computational methods.通过诱变、X射线晶体学和计算方法揭示的谷氨酸羧肽酶II的反应机制。
Biochemistry. 2009 May 19;48(19):4126-38. doi: 10.1021/bi900220s.
8
Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk.谷氨酸羧肽酶II基因变异在预测乳腺癌和前列腺癌风险中的临床应用
Cancer Genet. 2015 Nov;208(11):552-8. doi: 10.1016/j.cancergen.2015.09.001. Epub 2015 Sep 8.
9
Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study.挪威同质人群中谷氨酸羧肽酶II(GCPII)基因多态性与叶酸和同型半胱氨酸浓度以及认知、焦虑和抑郁评分的关系:霍达兰同型半胱氨酸研究
Am J Clin Nutr. 2007 Aug;86(2):514-21. doi: 10.1093/ajcn/86.2.514.
10
Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene.谷氨酸羧肽酶II基因不同基因型受试者中聚谷氨酸叶酸相对于单谷氨酸叶酸的生物利用度。
Am J Clin Nutr. 2004 Sep;80(3):700-4. doi: 10.1093/ajcn/80.3.700.

引用本文的文献

1
Predicting the effect of different folate doses on [Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling.使用基于生理的药代动力学模型预测不同叶酸剂量对[镓]镓-PSMA-11器官和肿瘤摄取的影响。
EJNMMI Res. 2023 Jun 15;13(1):60. doi: 10.1186/s13550-023-01008-y.
2
Characterization of Non-Specific Uptake and Retention Mechanisms of [Lu]Lu-PSMA-617 in the Salivary Glands.唾液腺中[镥]镥-PSMA-617的非特异性摄取和滞留机制的表征
Pharmaceuticals (Basel). 2023 May 3;16(5):692. doi: 10.3390/ph16050692.
3
Characterization of glutamate carboxypeptidase 2 orthologs in trematodes.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Structural basis for molecular recognition of folic acid by folate receptors.叶酸受体对叶酸的分子识别的结构基础。
Nature. 2013 Aug 22;500(7463):486-9. doi: 10.1038/nature12327. Epub 2013 Jul 14.
3
Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II.开发一种高通量荧光偏振分析法以鉴定谷氨酸羧肽酶II的新型配体。
鉴定扁形动物中的谷氨酸羧肽酶 2 同源物。
Parasit Vectors. 2022 Dec 20;15(1):480. doi: 10.1186/s13071-022-05556-5.
4
Metamorphosis of prostate specific membrane antigen (PSMA) inhibitors.前列腺特异性膜抗原(PSMA)抑制剂的蜕变
Biophys Rev. 2022 Jan 13;14(1):303-315. doi: 10.1007/s12551-021-00919-1. eCollection 2022 Feb.
5
The Impact of Monosodium Glutamate on Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study.谷氨酸单钠对前列腺癌患者 Ga-PSMA-11 生物分布的影响:一项前瞻性随机对照成像研究。
J Nucl Med. 2021 Sep 1;62(9):1244-1251. doi: 10.2967/jnumed.120.257931. Epub 2021 Jan 28.
6
Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.寻找错误地方的药物:GCPII 抑制剂在大脑外的应用。
Neurochem Res. 2020 Jun;45(6):1256-1267. doi: 10.1007/s11064-019-02909-y. Epub 2019 Nov 20.
7
Metal-Based PSMA Radioligands.基于金属的前列腺特异性膜抗原放射性配体
Molecules. 2017 Mar 24;22(4):523. doi: 10.3390/molecules22040523.
8
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.局部灌肠治疗抑制 FOLH1/GCPII 作为炎症性肠病的一种新疗法。
J Control Release. 2017 Oct 10;263:132-138. doi: 10.1016/j.jconrel.2017.01.036. Epub 2017 Jan 31.
9
/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities.IBD患者体内的GCPII水平升高,抑制它可改善小鼠IBD异常。
JCI Insight. 2016 Aug 4;1(12). doi: 10.1172/jci.insight.88634.
10
The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.前列腺特异性膜抗原/谷氨酸羧肽酶II(PSMA/GCPII)在癌症和神经疾病中的治疗与诊断潜力。
Br J Pharmacol. 2016 Nov;173(21):3041-3079. doi: 10.1111/bph.13576. Epub 2016 Sep 23.
J Biomol Screen. 2012 Sep;17(8):1030-40. doi: 10.1177/1087057112451924. Epub 2012 Jun 29.
4
Glutamate carboxypeptidase II: an overview of structural studies and their importance for structure-based drug design and deciphering the reaction mechanism of the enzyme.谷氨酸羧肽酶 II:结构研究概述及其在基于结构的药物设计和解析酶反应机制方面的重要性。
Curr Med Chem. 2012;19(9):1300-9. doi: 10.2174/092986712799462667.
5
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.谷氨酸羧肽酶 II 在神经紊乱和前列腺癌的诊断与治疗中的作用。
Curr Med Chem. 2012;19(6):856-70. doi: 10.2174/092986712799034888.
6
Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II.体内生物素化蛋白质的高效通用一步亲和纯化:重组人谷氨酸羧肽酶II的表达、表征及结构分析
Protein Expr Purif. 2012 Mar;82(1):106-15. doi: 10.1016/j.pep.2011.11.016. Epub 2011 Dec 8.
7
Current and Novel Inhibitors of HIV Protease.当前和新型 HIV 蛋白酶抑制剂。
Viruses. 2009 Dec;1(3):1209-39. doi: 10.3390/v1031209. Epub 2009 Dec 11.
8
Molecular identification of β-citrylglutamate hydrolase as glutamate carboxypeptidase 3.β-柠香醇丁二酸酶作为谷氨酸羧肽酶 3 的分子鉴定。
J Biol Chem. 2011 Nov 4;286(44):38220-38230. doi: 10.1074/jbc.M111.287318. Epub 2011 Sep 9.
9
Combined impact of polymorphism of folate metabolism genes; glutamate carboxypeptidase, methylene tetrahydrofolate reductase and methionine synthase reductase on breast cancer susceptibility in kashmiri women.叶酸代谢基因多态性;谷氨酸羧肽酶、亚甲基四氢叶酸还原酶和甲硫氨酸合酶还原酶的联合作用对克什米尔女性乳腺癌易感性的影响
Int J Health Sci (Qassim). 2008 Jan;2(1):3-14.
10
Overview of the CCP4 suite and current developments.CCP4软件包概述及当前进展
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42. doi: 10.1107/S0907444910045749. Epub 2011 Mar 18.